{"transactions":[{"id":962102,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-19T11:39:04.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/19/2025 and will vest in equal installments monthly, in arrears, over 36 months (1/36 per month)"}],"balance_after":49050,"derivative":{"exercise_price":1.29,"expiration_date":"2030-12-18","underlying":"Common shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001213900-25-123625","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390025123625/ownership.xml","form_type":"4"}},{"id":965171,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Expiration)","published_at":"2025-12-17T12:19:09.000Z","date":"2025-12-15","kind":"other","planned":false,"acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$1,925.00 using an exchange rate of C$1.3770 = $US1.00"}],"balance_after":14050,"derivative":{"exercise_price":1397.97,"exercise_date":"2020-12-16","expiration_date":"2025-12-15","underlying":"Common shares","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001213900-25-122647","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390025122647/ownership.xml","form_type":"4"}},{"id":1322921,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-23T09:20:10.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split."}],"balance_after":14300,"derivative":{"exercise_price":4.14,"expiration_date":"2029-12-19","underlying":"Common shares","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001213900-24-111552","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390024111552/ownership.xml","form_type":"4"}},{"id":1500567,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Expiration)","published_at":"2024-05-28T16:26:32.000Z","date":"2024-05-27","kind":"other","planned":false,"acquired":false,"shares":1139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00"}],"balance_after":161000,"derivative":{"exercise_price":263.18,"exercise_date":"2019-05-27","expiration_date":"2024-05-27","underlying":"Common shares","underlying_shares":1139},"source":{"system":"sec-edgar","filing":"0001213900-24-047094","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390024047094/ownership.xml","form_type":"4"}},{"id":1629596,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-02-21T14:58:17.000Z","date":"2024-02-20","kind":"purchase","planned":false,"acquired":true,"shares":41600,"price":0.3587,"value":14921.92,"ownership":{"direct":true},"balance_after":43959,"source":{"system":"sec-edgar","filing":"0001213900-24-015703","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390024015703/ownership.xml","form_type":"4"}},{"id":1700187,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-26T13:07:20.000Z","date":"2023-12-23","kind":"grant","planned":false,"acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month)."}],"balance_after":162139,"derivative":{"exercise_price":0.37,"expiration_date":"2028-12-22","underlying":"Common shares","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0001213900-23-098489","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390023098489/ownership.xml","form_type":"4"}},{"id":1891695,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Expiration)","published_at":"2023-05-16T17:58:35.000Z","date":"2023-05-16","kind":"other","planned":false,"acquired":false,"shares":1818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$841.50 using an exchange rate of C$1.3487 = $US1.00"}],"balance_after":26139,"derivative":{"exercise_price":623.93,"exercise_date":"2018-05-16","expiration_date":"2023-05-16","underlying":"Common shares","underlying_shares":1818},"source":{"system":"sec-edgar","filing":"0001213900-23-040577","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390023040577/ownership.xml","form_type":"4"}},{"id":1961189,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Expiration)","published_at":"2023-03-09T15:43:46.000Z","date":"2023-03-08","kind":"other","acquired":false,"shares":545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$1,278.75 using an exchange rate of C$1.3785 = $US1.00"}],"balance_after":27957,"derivative":{"exercise_price":927.64,"exercise_date":"2018-03-08","expiration_date":"2023-03-08","underlying":"Common shares","underlying_shares":545},"source":{"system":"sec-edgar","filing":"0001213900-23-018866","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390023018866/ownership.xml","form_type":"4"}},{"id":2081838,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-19T16:50:43.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":28502,"derivative":{"exercise_price":1.78,"expiration_date":"2027-12-15","underlying":"Common shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-22-080967","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390022080967/ownership.xml","form_type":"4"}},{"id":2110498,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-11-18T19:34:18.000Z","date":"2022-11-14","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 15,000 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 13,502 derivative securities of the Issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 15,000 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 13,502 derivative securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the Issuer's common stock was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 15,000 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 13,502 derivative securities of the Issuer."}],"balance_after":13502,"derivative":{"exercise_price":2.78,"expiration_date":"2027-11-13","underlying":"Common shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-22-073943","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390022073943/ownership.xml","form_type":"4/A","original_submission_date":"2022-11-15"}},{"id":2116347,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-11-15T19:44:32.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":28502,"derivative":{"exercise_price":2.78,"expiration_date":"2027-11-13","underlying":"Common shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-22-072920","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390022072920/ownership.xml","form_type":"4"}},{"id":2247739,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Expiration)","published_at":"2022-06-02T14:50:27.000Z","date":"2022-06-02","kind":"other","acquired":false,"shares":13636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$14.85 using an exchange rate of C$1.2639 = $US1.00"}],"balance_after":337576,"derivative":{"exercise_price":11.75,"exercise_date":"2017-06-02","expiration_date":"2022-06-02","underlying":"Common shares","underlying_shares":13636},"source":{"system":"sec-edgar","filing":"0001213900-22-030914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390022030914/ownership.xml","form_type":"4"}},{"id":2295737,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-04-18T11:46:50.000Z","date":"2022-04-14","kind":"purchase","acquired":true,"shares":14160,"price":0.894,"value":12659.04,"ownership":{"direct":true},"balance_after":59003,"source":{"system":"sec-edgar","filing":"0001213900-22-020314","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390022020314/ownership.xml","form_type":"4"}},{"id":2297834,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-04-13T21:43:05.000Z","date":"2022-04-13","kind":"purchase","acquired":true,"shares":8560,"price":0.85,"value":7276.0,"ownership":{"direct":true},"balance_after":44843,"source":{"system":"sec-edgar","filing":"0001213900-22-019688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390022019688/ownership.xml","form_type":"4"}},{"id":2427881,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Expiration)","published_at":"2022-01-24T16:18:40.000Z","date":"2022-01-24","kind":"other","acquired":false,"shares":60606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from the Canadian dollar exercise price of C$3.63 using an exchange rate of C$1.2554 = $US1.00"}],"balance_after":351212,"derivative":{"exercise_price":2.89,"exercise_date":"2016-06-15","expiration_date":"2022-01-24","underlying":"Common shares","underlying_shares":60606},"source":{"system":"sec-edgar","filing":"0001213900-22-003333","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390022003333/ownership.xml","form_type":"4"}},{"id":2427880,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Expiration)","published_at":"2022-01-24T16:18:40.000Z","date":"2022-01-24","kind":"other","acquired":false,"shares":60606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$2.64 using an exchange rate of C$1.2554 = $US1.00"}],"balance_after":411818,"derivative":{"exercise_price":2.1,"exercise_date":"2016-05-16","expiration_date":"2022-01-24","underlying":"Common shares","underlying_shares":60606},"source":{"system":"sec-edgar","filing":"0001213900-22-003333","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390022003333/ownership.xml","form_type":"4"}},{"id":2539479,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-19T18:20:46.000Z","date":"2021-10-18","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 10/18/2021 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."}],"balance_after":472424,"derivative":{"exercise_price":1.4,"expiration_date":"2026-10-17","underlying":"Common shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-21-053583","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390021053583/ownership.xml","form_type":"4"}},{"id":2555853,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-09-30T13:39:11.000Z","date":"2021-09-29","kind":"purchase","acquired":true,"shares":8800,"price":1.73,"value":15224.0,"ownership":{"direct":true},"balance_after":36283,"source":{"system":"sec-edgar","filing":"0001213900-21-050751","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390021050751/ownership.xml","form_type":"4"}},{"id":2556776,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-09-29T14:00:25.000Z","date":"2021-09-28","kind":"purchase","acquired":true,"shares":11400,"price":1.753,"value":19984.2,"ownership":{"direct":true},"balance_after":27483,"source":{"system":"sec-edgar","filing":"0001213900-21-050522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390021050522/ownership.xml","form_type":"4"}},{"id":2938168,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71099,"kind":"person","name":"ADAMS ERIC A","position":1,"cik":"0001817882","reported_name":"ADAMS ERIC A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-18T06:08:43.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted on 12/16/2020 and will vest as follows: 25% on 6/16/2021; 25% on 12/16/2021; 25% on 6/16/2022; and 25% on 12/16/2022."}],"balance_after":125000,"derivative":{"exercise_price":3.02,"expiration_date":"2025-12-15","underlying":"Common shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-20-043355","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817882/000121390020043355/ownership.xml","form_type":"4"}}]}